HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by McHugh, T D Articles by Gillespie, S H Search for Related Content PubMed PubMed Citation Articles by McHugh, T D Articles by Gillespie, S H Agricola Articles by McHugh, T D Articles by Gillespie, S H

Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples

¹Centre for Medical Microbiology, Department of Infection, Royal Free & University College Medical School, Pond Street, London NW3 2PF, UK ²Department of Thoracic Medicine, Royal Free Hospital NHS Trust, Pond Street, London NW3 2PF, UK

Correspondence T. D. McHugh t.mchugh{at}rfc.ucl.ac.uk

Received June 16, 2004
Accepted August 18, 2004

Nucleic acid amplification techniques (NAATs) have been demonstrated to make significant improvements in the diagnosis of tuberculosis (TB), particularly in the time to diagnosis and the diagnosis of smear-negative TB. The BD ProbeTec strand displacement amplification (SDA) system for the diagnosis of pulmonary and non-pulmonary tuberculosis was evaluated. A total of 689 samples were analysed from patients with clinically suspected TB. Compared with culture, the sensitivity and specificity for pulmonary samples were 98 and 89 %, and against final clinical diagnosis 93 and 92 %, respectively. This assay has undergone limited evaluation for non-respiratory samples and so 331 non-respiratory samples were tested, identifying those specimens that were likely to yield a useful result. These were CSF (n = 104), fine needle aspirates (n = 64) and pus (n = 41). Pleural fluid (n = 47) was identified as a poor specimen. A concern in using the SDA assay was that low-positive samples were difficult to interpret; 7.8 % of specimens fell into this category. Indeed, 64 % of the discrepant results, when compared to final clinical diagnosis, could be assigned as low-positive samples. Specimen type did not predict likelihood of a sample being in the low-positive zone. Although the manufacturers do not describe the concept of a low-positive zone, we have found that it aids clinical diagnosis.

This article has been cited by other articles:

				R A M Breen, S M Barry, C J Smith, R J Shorten, J P Dilworth, I Cropley, T D McHugh, S H Gillespie, G Janossy, and M C I Lipman Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis Thorax, January 1, 2008; 63(1): 67 - 71. [Abstract] [Full Text] [PDF]

				D. C. Bean, A. Hills, T. Ryan, and J. Aitken Evaluation of the BD ProbeTec ET System for Direct Detection of Mycobacterium bovis in Veterinary Specimens J. Clin. Microbiol., October 1, 2007; 45(10): 3434 - 3435. [Abstract] [Full Text] [PDF]

				K. J. Williams, C. L. Ling, C. Jenkins, S. H. Gillespie, and T. D. McHugh A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory J. Med. Microbiol., May 1, 2007; 56(5): 598 - 602. [Abstract] [Full Text] [PDF]

				S Greco, E Girardi, A Navarra, and C Saltini Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis Thorax, September 1, 2006; 61(9): 783 - 790. [Abstract] [Full Text] [PDF]